EXAS News 12.84 Exact Sciences Corp (EXAS)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Exact Sciences Corp (EXAS) 12.84 $EXAS

Exact Sciences Falls 3.86% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Apr 14, 6:02PM CDT
Exact Sciences (NASDAQ:EXAS) traded in a range yesterday that spanned from a low of $11.51 to a high of $12.76. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $12.25 on volume of 2.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Exact Sciences Announces Successful Completion of Public Offering of Common Stock
Business Wire - Wed Apr 09, 3:05PM CDT
Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its previously announced underwritten public offering of its common stock at a price of $12.75 per share to the public.

Stocks Review on Top Gainers -- Research on Genco Shipping & Trading, Exact Sciences, Baltic Trading, and Eagle Bulk Shipping
PR Newswire - Mon Apr 07, 11:38AM CDT
The US markets saw a negative sentiment on Friday, April 4, 2014, with the NASDAQ Composite closing at 4,127.73, down 2.60%, the Dow Jones Industrial Average ending the session at 16,412.71, down 0.96%, and the S&P 500 declining 1.25% to finish the trading session at 1,865.09. The session witnessed selling pressure in the Information Technology, Consumer Discretionary, Health Care, and Materials sectors that negatively impacted the broader market. A number of stocks saw large movements, including Genco Shipping & Trading Ltd (NYSE: GNK), Exact Sciences Corp. (NASDAQ: EXAS), Baltic Trading Ltd (NYSE: BALT) and Eagle Bulk Shipping Inc. (NASDAQ: EGLE). Free technical research on GNK, EXAS, BALT and EGLE can be downloaded upon signing up at:

Nasdaq stocks posting largest percentage increases
AP - Fri Apr 04, 5:20PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

Why Exact Sciences (EXAS) Stock Is Higher On Friday
at The Street - Fri Apr 04, 8:56AM CDT
Shares of Exact Sciences (EXAS) are up 5.30% to $13.60 after the molecular diagnostics company announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a price of $12.75 per share to the public.

Exact Sciences Prices Public Offering of Common Stock
Business Wire - Fri Apr 04, 7:42AM CDT
Exact Sciences Corp. (NASDAQ: EXAS) today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a price of $12.75 per share to the public. The net proceeds to Exact from this offering are expected to be approximately $119.7 million, after deducting underwriting discounts and commissions and other estimated offering expenses payable by Exact. The offering is expected to close on or about April 9, 2014, subject to the satisfaction of customary closing conditions. Exact has granted the underwriters a 30-day option to purchase up to an aggregate of 1,500,000 additional shares of common stock. Exact anticipates using the net proceeds from the offering to fund its efforts to obtain FDA approval of its Cologuard test, to fund Cologuard commercialization activities, to fund product development efforts, and for general corporate and working capital purposes.

Exact Sciences Announces Proposed Public Offering of Common Stock
Business Wire - Wed Apr 02, 3:01PM CDT
Exact Sciences Corp. (NASDAQ: EXAS) today announced that it is offering $125 million of shares of its common stock in a proposed underwritten public offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The shares will be issued pursuant to a prospectus supplement to be filed as part of a shelf registration statement filed with the Securities and Exchange Commission (SEC) on Form S-3.

Exact Sciences (EXAS) Jumps: Stock Adds 10.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 7:51AM CDT
Exact Sciences Corporation was a big mover last session, as its shares rose over 10% on the day.

Why Exact Sciences, Builders FirstSource, and Clayton Williams Energy Jumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Mon Mar 31, 7:00PM CDT
Over the weekend, investors who tuned into 60 Minutes got a look at the new Michael Lewis book on high-frequency trading, with dire conclusions about how traders take advantage of both institutional and individual investors. Yet even with that...

Today's Dead Cat Bounce Stock Is Exact Sciences Corporation (EXAS)
at The Street - Mon Mar 31, 8:45AM CDT
Trade-Ideas LLC identified Exact Sciences Corporation (EXAS) as a "dead cat bounce" (down big yesterday but up big today) candidate

CBS Outdoor Americas Climbs on First Day of Trading; FDA Advisory Panel Recommends Approval of Exact Sciences Corporation's Cologuard
ACCESSWIRE - Sun Mar 30, 11:16PM CDT
CBS Outdoor Americas Inc. (NYSE: CBSO) - For an in-depth report on CBS Outdoor Americas Inc. follow: www.BullTrends.com/stockquote/CBSO

'Mad Money' Lightning Round: Sell Starbucks at $72
at The Street - Sat Mar 29, 5:00AM CDT
Cramer prefers Boeing over AerCap Holdings and CBS Outdoor over Chambers Street Properties.

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Mar 28, 7:21PM CDT
Cramer says the market needs both a China stimulus plan and positive U.S. employment numbers to sustain any gains.

Look for Shares of Exact Sciences to Potentially Rebound after Yesterday's 6.47% Sell Off
Comtex SmarTrend(R) - Fri Mar 28, 4:34PM CDT
Exact Sciences (NASDAQ:EXAS) traded in a range yesterday that spanned from a low of $12.52 to a high of $14.60. Yesterday, the shares fell 6.5%, which took the trading range below the 3-day low of $13.61 on volume of 9.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Exact Sciences Corporation (EXAS) Falls Further As It's Water-Logged And Getting Wetter
at The Street - Fri Mar 28, 11:33AM CDT
Trade-Ideas LLC identified Exact Sciences Corporation (EXAS) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Morning Movers in Biotech: Ariad Pharmaceuticals, Exact Sciences Corporation and MannKind Corp
George Budwell, The Motley Fool - Motley Fool - Fri Mar 28, 7:59AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a look at the top stories in biotech and health...

Exact Sciences Announces FDA Advisory Committee Unanimously Recommends Approval of Cologuard
Business Wire - Thu Mar 27, 2:52PM CDT
Exact Sciences Corp. (Nasdaq: EXAS) today announced that the U.S. Food and Drug Administration's (FDA) Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee determined by a unanimous vote of 10 to zero that Exact Sciences has demonstrated safety, effectiveness and a favorable risk benefit profile of Cologuard(R), the company's stool-based DNA (sDNA), non-invasive colorectal cancer screening test.

Morning Movers in Biotech: Clovis Oncology, Inc., Exact Sciences Corporation, GlaxoSmithKline PLC, a
George Budwell, The Motley Fool - Motley Fool - Thu Mar 27, 8:00AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a look at the top stories in biotech and health...

Exact Sciences' Stock Trading Halted Today; FDA Advisory Committee Meeting to Review Premarket Approval Application
Business Wire - Thu Mar 27, 6:03AM CDT
Exact Sciences Corp. (Nasdaq: EXAS) today announced that the Nasdaq Stock Market has halted trading of the company's stock.

Correction: DNA Stool Test-FDA story
By MATTHEW PERRONE - AP - Tue Mar 25, 2:27PM CDT
WASHINGTON (AP) — In a story March 24 about colon cancer screening tests, The Associated Press reported erroneously that the Colosure test from LabCorp is approved by the Food and Drug Administration. It has not been approved by the agency. The story also incorrectly stated that another test from Epigenomics is a stool test. It is a blood test.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Precision Metal Forming Is Industry's Quiet Backbone

Updated Category News Views 205

A fraction of a millimeter can turn a perfectly good industrial part into an expensive headache. That unglamorous reality sits at the center of Michele Caulfield's discussion of precision metal forming for HelloNation, and it deserves more attention than it usually gets. Investors watching manufacturing tend to chase flashy automation headlines, big aerospace orders, or...

Continue Reading
Five Films Put Modern Infrastructure Under a Lens

Updated Category News Views 12

Most infrastructure only earns a thought when it breaks, and that is precisely the nerve these films are trying to touch. Nicely Done Productions has released the final five installments of its ten-part Threads of Connectivity documentary series, hosted on National Geographic's global digital platform. The subjects are illycaffè, Cargill, Honeywell Aerospace, Western...

Continue Reading
Why Lear’s PACE Award Matters Beyond Seat Warmers Today

Updated Category News Views 94

Seat foam and wiring seldom make investors sit upright, yet Lear has managed to turn that unglamorous corner of the vehicle into something worth watching. The company’s Modular Thermal Comfort Systems just won a 2026 Automotive News PACE Award, a respected supplier-industry nod for innovation and business performance. Awards alone do not pay anybody’s bills, and I...

Continue Reading
Century Complete Tests Conway Demand Near Myrtle Beach

Updated Category News Views 108

Ninety-four lots in Conway may not move Wall Street by themselves, but they can say plenty about the kind of buyer Century Communities is chasing. Century Complete is opening its model at Cates Bay Crossing on Nov. 21, 2026, with single-family homes starting in the $260s. In a housing market where affordability gets talked to death and rarely delivered cleanly, that...

Continue Reading
Dar Global’s $700M Qatar Bet Leans on Trump Branding

Updated Category News Views 0

Luxury property launches rarely arrive quietly, and this one came wrapped in Palm Beach ceremony, championship golf and a very loud brand name. Dar Global has formally introduced Trump International Simaisma, Qatar, a QAR 2.5 billion development—about $700 million—alongside The Trump Organization. That is a meaningful chunk of real estate ambition, not a little side...

Continue Reading
TORM Rejects Hafnia's No-Premium Merger Pitch Again

Updated Category News Views 120

A 19.8% shareholder heading for the exit can rattle a shipping stock before breakfast, and TORM has answered the noise with a flat refusal to pretend Hafnia's merger approach was good enough. The message from Hellerup on November 18 is unusually blunt: Hafnia made several conditional, all-share proposals, TORM saw no effective premium for control, and the board rejected...

Continue Reading
Ambition Links Call Scoring to the Coaching Room Faster

Updated Category News Views 91

A sales call dies twice when nobody turns the recording into practice. First it ends with the prospect, then it vanishes into a pile of transcripts, dashboards, and manager good intentions. Ambition’s new Call Intelligence feature is aimed squarely at that second failure. It brings Gong calls, transcripts, scorecards, and trackers into Ambition’s coaching workflow,...

Continue Reading
Seeking Alpha Premium Review: Data Meets Human Judgment

Updated Category News Views 199

A spreadsheet can spot a cracked windshield, but it cannot tell you where the truck is headed. That is the useful, slightly irritating truth behind Seeking Alpha Premium’s 2026 pitch: it puts an enormous amount of stock-research machinery in one place, yet the investor still has to do the driving. Software Experts has highlighted the service in its review of...

Continue Reading
Tonum and Euvita Link Supplements to Personalized Care

Updated Category News Views 51

Muscle loss has become the awkward footnote in the GLP-1 weight-loss boom, and Tonum Health is trying to put that concern nearer the center of the care conversation. Its newly announced partnership with euvita health places Tonum's supplements and functional nutrition products inside a physician-led platform built around biomarker testing, hormone and peptide therapy,...

Continue Reading
Another Nine's A9OS Puts Software at Center of Golf

Updated Category News Views 115

A golf simulator chain is trying to turn the boring plumbing into its sharpest club. Another Nine’s A9OS is not merely a booking widget dressed up for a franchise brochure; it is meant to run the whole 24/7 operation, from payments and door access to cameras, simulator support and guest help. That ambition deserves attention because this is exactly where a staff-free...

Continue Reading

Top 5 Most Recently Viewed Articles

Bunzl Reports Strong Performance and Strategic Acquisitions

Updated Category News Views 675

Bunzl Reports Strong Growth and Strategic Acquisitions Recently, Bunzl plc (OTC: BZLFY), a leading international distribution and services group, showcased its resilience with a reported 5.4% increase in group revenue at constant exchange rates for the most recent quarter. This growth, noted from the quarter ending June 30, 2024, presents a nuanced picture alongside a...

Continue Reading
Experience RainFocus: INSIGHT 2026 Event Essentials

Updated Category News Views 386

Exciting Announcement for INSIGHT 2026 Event RainFocus unveils the theme "Connecting Journeys" for its highly anticipated event. INSIGHT 2026 is set to happen Nov. 5, featuring a focus on creating seamless experiences throughout customer journeys. Connecting Journeys: The Theme for 2026 RainFocus, known for its innovative event marketing platform, has officially announced...

Continue Reading
UK Economic Activity Declines as Job Cuts Accelerate Amid Budget Fallout

Updated Category News Views 160

UK Economic Activity Experiences Significant Slowdown As the year comes to a close, UK business activity has shown a significant slowdown, with employers now forced to cut jobs at an alarming rate. Recent findings from a Purchasing Managers' Index (PMI) survey have painted a bleak picture of the economic landscape, prompting concerns about the future of various sectors....

Continue Reading
Irwin W. Aronson Honored Among Influential Leaders Over 50

Updated Category News Views 207

Irwin W. Aronson Recognized for Contributions to Public Service Irwin W. Aronson has recently received a notable honor from City & State Pennsylvania. He has been named one of the esteemed Fifty Over 50 honorees, a tribute to individuals whose trailblazing work significantly shapes the future of their communities. This recognition showcases Aronson’s dedication and...

Continue Reading
Axiom Medical Welcomes Kevin Campbell as CFO to Lead Growth

Updated Category News Views 43

Axiom Medical Welcomes Kevin Campbell as New CFO Axiom Medical, a leader in occupational health services, has made a significant move by appointing Kevin Campbell as its new Chief Financial Officer. This decision reflects the company’s dedication to improving its financial management and service delivery. Kevin officially took on this important role on September 1,...

Continue Reading